Polyhydroquinone-graphene composite as a new redox species was synthesized simply by a microwaveassisted one-pot method through oxidative polymerization of hydroquinone by graphene oxide, which exhibited excellent electrochemical redox activity at 0.124 V and can remarkably promote electron transfer. The as-prepared composite was used as immunosensing substrate in a label-free electrochemical immunosensor for the detection of cytokeratins antigen 21-1, a kind of biomarker of lung cancer. The proposed immunosensor showed wide liner range from 10 pg mL −1 to 200 ng mL −1 with a detection limit 2.3 pg mL −1 , and displayed a good stability and selectivity. In addition, this method has been used for the analysis of human serum sample, and the detection results showed good consistence with those of ELISA. The present substrate can be easily extended to other polymer-based nanocomposites.
Si, C, O, and Si elements can be observed in rGO&PHQ. The Si element is displayed since silicon slice was used as the sample platform. Compared with rGO&PHQ, Au element in rGO&PHQ-Au composite can be observed. This indicated that the AuNPs are successfully deposited on rGO&PHQ composite.
The Raman spectra of GO and rGO&PHQ composites were shown in Fig. 2 . Two characteristics peaks are generally known D and G bands of GO. The D and G bands of GO were appeared at 1350 and 1597 cm −1 , respectively, with the intensity ratio (I D /I G ) of 0.99. In comparison with GO, the G band of rGO&PHQ composite slightly shifted to the lower wavenumbers which indicated the reduction in GO after the microwave irradiation 20 . The FT-IR spectrum of rGO&PHQ is quite different from that of HQ 21 . The broad band at 3500 cm −1 is attributed to the stretching of O-H in hydroxide or water. The strong band at 1651 cm −1 is assigned to the stretching of C= O. This band is stronger in the rGO&PHQ composite compared with that in HQ, because the phenolic hydroxyl groups in rGO&PHQ were oxidized by GO to be quinone structures. The bands at 1194 cm −1 and 756 cm −1 are associated with C-O stretching and C-H bending, respectively. During the experiment, the color of the sample changes from brown to dark, indicating the GO (brown) was reduced to be rGO (black).
Electrochemical impedance spectroscopy (EIS) was used to investigate the interfacial properties of the electrode modified with rGO&PHQ composite. The Nyquist plot of rGO&PHQ modified GCE (Fig. 3A, curve b) showed a semicircle with smaller diameter compared to the bare glassy carbon electrode (GCE) (Fig. 3A, curve a) , which indicated a small charge transfer resistance. It was because the polyhydroquinone-graphene composite can remarkedly promote electron transfer ability. After the deposition of Au film, the resistance was further decreased (Fig. 3A, curve c) , indicating the doposited Au film can effectively promote the electron transfer. Importantly, the polyhydroquinone-graphene composite exhibited excellent electrochemical redox activity at 0.124 V, which it is precondition to be used as immunosensing substrate in a label-free electrochemical immunosensor.
For an electrochemical biosensor, its performance is critically dependent on the properties of the immunosensing interface [22] [23] [24] [25] [26] . The immunosensing substrate with reversible redox potential, high specific surface area, and excellent conductivity played a crucial role in the detection limit, linear range, and sensitivity [27] [28] [29] [30] [31] [32] [33] . The principle of the proposed immunosensor was illustrated in Fig. 4 . A stable film of rGO&PHQ composite was easily formed on GCE simply by dropping method. Meanwhile, the electrodeposited AuNPs on the rGO&PHQ composite can further increase the specific surface area to capture a lot of antibodies as well as improve the capability of electron transfer. After fixing anti-CYFRA21-1 and blocking with BSA, the immunosensing interface was realized. Due to the poor conductivity of proteins such as CYFRA21-1 and anti-CYFRA21-1, the current decrease will be observed. The current responses at 0.124 V were proportionate to the logarithm values of CYFRA21-1 concentrations. In this case, the concentration of CYFRA21-1 can be measured. The fabrication process of the immunosensor was monitored by differential pulse voltammetry (DPV) in PBS buffer (Fig. 5) . The current response of GCE modified with rGO&PHQ-Au composite (curve b) was higher than that of rGO&PHQ composite modified GCE (curve a). This was attributed to the excellent conductivity of AuNPs and the increase of the surface area of the electrode. In contrast, the loading of anti-CYFRA21-1 led to an obvious decrease of the peak current (curve c). The current response further decreased after the immunosensor was blocked with BSA (curve d) and incubated in a solution with 1 ng mL −1 CYFRA21-1 (curve e). The pH value of detection solution directly influences the activity of the antibodies. In this case, the effect of the pH on the immune reaction was investigated. As shown in Figure S2A , with in increase of pH value, the peak current increased when the pH value was less than 5.5, and then decreased with the increase of pH value when pH value was more than 5.5. So, pH 5.5 was used in following experiments. In order to optimize the incubation time, the effect of the incubation time on the immune reaction was also studied. As shown in Figure S2B , the peak current increased with the increase of the incubation time, and then kept constant after 45 min. In this case, 45 min was used as the incubation time for the immunoassay.
The analytical performance of this immunosensor was tested by DPV. The current response of the immunosensor decreased with the increase of CYFRA21-1 concentration (Fig. 6A) . The immunosensor displayed good linear relation ranging from 10 pg mL −1 to 200 ng mL −1 (Fig. 6B ) with a low detection limit 2.3 pg mL −1 (the ratio of signal to noise (S/N) = 3). In order to investigate the anti-interfering ability of the proposed immunosensor, the analytical performance using neuron-specific enolase (NSE), alpha fetoprotein (AFP), prostate specific antigen (PSA), UA, glucose, AA, BSA, and IgG as analyte instead of CYFRA21-1 was investigated. When the immunosensor was incubated with 100 ng mL −1 AA, UA, NSE, AFP, BSA, IgG, PSA, and glucose solution, respectively, no obvious changes of the current were observed compared to the blank test (no target molecule) in the same testing conditions as shown in Figure S3 . However, when CYFRA21-1 was coexisted with the interferences, the electrochemical responses were almost the same as that with only CYFRA21-1. All these results indicated that the proposed immunosensor had a good specificity for CYFRA21-1. To further examine the stability of the immunoassay, the present immunosensor was stored at 4 °C for about four weeks and then its electrochemical property was measured. The change of current response was less than 10%, revealing that the stability of the immunoassay was good. The repeatability was also studied using three electrodes, and the relative standard deviation was 4.52%, showing that the repeatability of the immunosensor was acceptable.
In order to investigate the reliability and accuracy of the proposed immunosensor for clinical sample, sixteen clinical serum samples containing CYFRA21-1 were analyzed. The obtained results were compared with the ELISA tests (Table 1) . It can be seen that the relative standard error was less than 6%, indicating this electrochemical immunoassay had a good accuracy for clinical sample detections. Thus, the immunosensor had a potential application for the detection of CYFRA21-1 in clinical diagnostics.
Conclusion
In summary, a novel electrochemical redox-active polyhydroquinone-graphene composite was synthesized by a one-pot method by oxidative polymerization of hydroquinone by graphene oxide, which exhibited excellent electrochemical redox activity at 0.124 V and good conductivity. The as-prepared composite was used as sensing substrate in the fabricating label-free electrochemical immunosensor for the detection of cytokeratins antigen 21-1. The proposed immunosensor showed a good analytical performance. A wide detection ranges from 10 pg mL −1 to 200 ng mL −1 and the detection limit 2.3 pg mL −1 was reached. Besides, the detection results of human serum sample by this immunosensor were in good consistence with ELISA ones. This new sensing substrate can be easily extended to other polymer-based nanocomposites, which is of significance for the label-free electrochemical immunosensors. Apparatus. All electrochemical measurements were carried out on a CHI832 electrochemical workstation (Chenhua Instrumentsn Co., Shanghai, China). SEM images and EDS were determined with a Hitachi SU8010 SEM. Ultrapure water used in all procedures was purified through an Olst ultrapure K8 apparatus (Olst, Ltd., resistivity > 18 MΩ). A three electrochemical system in the experiment was composed of a GCE (4 mm in diameter) as the working electrode, a Platinum wire and a Ag/AgCl electrode as counter electrode and reference electrode, respectively. Fourier transform infrared spectroscopy (FTIR) spectrum was obtained from FTIR spectroscopy (Tensor37, Bruker, Germany).
Preparation of polyhydroquinone-graphene composite. The polyhydroquinone-graphene composite was synthesized by adding hydroquinone (1 mmol) to graphene oxide (0.5 mg mL −1 , 5 mL), then microwave-assisted one-pot method through oxidative polymerization. The composites were centrifuged at 16000 rpm about 20 min and were washed with ultrapure water for several times. Ultimately, the composites were redispersed in 1 mL ultrapure water.
Fabrication of immunosensor.
The GCE was polished with alumina powders of 0.05 μ m, which was followed by ultrasonic processing in ultrapure water and then dried by N 2 . After that, 15 μ L solution of rGO&PHQ was dropped on the surface of a pretreated GCE and allowed for 30 min to form a thin homogeneous film. The electrode modified with rGO&PHQ was socked in HAuCl 4 diluted solution, then a depositional potential of − 0.2 V for 30 s was used to form Au film. Then the modified electrode was rinsed with ultrapure water. Then, 80 μ L 200 μ g mL −1 capture antibodies (anti-CYFRA21-1) were dropped on the rGO&PHQ/Au-modified GCE and incubated for 12 h at 4 °C to anchor the antibody to the surface of electrode. Subsequently, 20 μ L 1 wt% BSA was used to block the nonspecific active sites. After washed with purified water, the modified electrode was obtained and stored in 4 °C before use.
Sample
Proposed immunosensor (ng mL −1 ) ELISA (ng mL −1 ) Relative error (%) Table 1 . Assay results of clinical serum samples using the proposed and ELISA.
